Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Song Mu

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Iscience|November 7, 2022
Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in miceFeng-Xia Gao, Rui-Xin Wu, Mei-Ying Shen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2021
Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II StudyXiaohua Wu, Jianqing Zhu, Jing Wang, et al.
Frontiers in Immunology|April 8, 2021
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2Xiaojian Han, Yingming Wang, Shenglong Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 25, 2016
Clinical and Virological Characteristics of Ebola Virus Disease Patients Treated With Favipiravir (T-705)-Sierra Leone, 2014Chang-Qing Bai, Jin-Song Mu, David Kargbo, et al.
Nature Communications|November 3, 2021
Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variantsTingting Li, Xiaojian Han, Chenjian Gu, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 3, 2015
Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patientsJin Li, Hui-Juan Duan, Hao-Yang Chen, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Iscience|November 7, 2022
Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in miceFeng-Xia Gao, Rui-Xin Wu, Mei-Ying Shen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2021
Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II StudyXiaohua Wu, Jianqing Zhu, Jing Wang, et al.
Frontiers in Immunology|April 8, 2021
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2Xiaojian Han, Yingming Wang, Shenglong Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 25, 2016
Clinical and Virological Characteristics of Ebola Virus Disease Patients Treated With Favipiravir (T-705)-Sierra Leone, 2014Chang-Qing Bai, Jin-Song Mu, David Kargbo, et al.
Nature Communications|November 3, 2021
Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variantsTingting Li, Xiaojian Han, Chenjian Gu, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 3, 2015
Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patientsJin Li, Hui-Juan Duan, Hao-Yang Chen, et al.
Pageof 7